The status of antimicrobial resistance of Helicobacter pylori in Eastern Azerbaijan, Iran: comparative study according to demographics

Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
Morteza MilaniYaeghob Sharifi

Abstract

Helicobacter pylori-associated infections are extremely common in Iran, but few data about antibiotic sensitivity of H. pylori are available for this region. The purpose of this study was to investigate the prevalence of resistance in isolates against commonly used antibiotics in Eastern Azerbaijan, Iran, and the dependence of prevalence on the sex and age of patients. H. pylori isolates were collected by culture from gastric biopsies. Antibiotic susceptibility of isolates was determined by use of the disk agar diffusion test, and the minimum inhibitory concentration of clarithromycin was established by use of the Etest. A total 395 of biopsy specimens were studied; 112 samples of H. pylori were isolated (28.3 %), 55 (49 %) from males and 57 (51 %) from females. The prevalence of resistance to clarithromycin, metronidazole, erythromycin, amoxicillin, ciprofloxacin, rifampin, nitrofurantoin, and tetracycline were 16 (14.3 %), 86 (76.8 %), 29 (26.0 %), 32 (28.6 %), 37 (33.0 %), 32 (28.6 %), 13 (11.6 %), and 21 (18.7 %), respectively. Antimicrobial resistance was not statistically significantly associated with sex or age. Furthermore, the prevalence of resistance to metronidazole was high and that to clarithromycin was reasonable,...Continue Reading

References

Jul 2, 1999·International Journal of Antimicrobial Agents·T AlarcónM López-Brea
Feb 24, 2001·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·A PilottoUNKNOWN Interdisciplinary Group for the Study of Ulcer
Aug 2, 2001·The Journal of Antimicrobial Chemotherapy·M López-BreaT Alarcón
Oct 12, 2001·Journal of Gastroenterology and Hepatology·J YakoobZ Zhang
May 11, 2002·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·B GrignonJ L Fauchère
Apr 8, 2004·Helicobacter·Farahnaz NarimanTahereh Falsafi
Jan 19, 2006·Annals of Internal Medicine·Vincenzo De FrancescoEnzo Ierardi
Oct 11, 2007·Helicobacter·B J EganC A O'Morain
Nov 6, 2007·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Mandana RafeeyAsghar Ashrafy Hafez
Apr 1, 2010·European Journal of Gastroenterology & Hepatology·Anthony O'connorColm O'moráin
Nov 16, 2010·Helicobacter·Amin Talebi Bezmin AbadiLutz Wolfram
Aug 9, 2011·Expert Review of Anti-infective Therapy·Michael SelgradPeter Malfertheiner

❮ Previous
Next ❯

Citations

Dec 24, 2013·World Journal of Gastroenterology : WJG·Enzo IerardiMariabeatrice Principi
May 9, 2014·Diagnostic Microbiology and Infectious Disease·Lyudmila BoyanovaIvan Mitov
May 20, 2014·International Journal of Antimicrobial Agents·Shahrbanoo Keshavarz Azizi RaftarHamed Mirzaei Ghazi Kalayeh
Nov 7, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Kianoosh DadashzadehAbolfazl Akbarzadeh
Sep 1, 2015·Gastroenterology Clinics of North America·David Y Graham, Sun-Young Lee
Aug 22, 2014·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Shahrbanoo Keshavarz Azizi RaftarKamran Dastehgoli
Oct 5, 2016·Middle East Journal of Digestive Diseases·Saman AlhooeiZohreh Bari
Dec 12, 2017·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Arshid Yousefi-AvarvandFarzad Khademi
Nov 12, 2015·World Journal of Gastrointestinal Pharmacology and Therapeutics·Su Young KimJun-Won Chung
Aug 19, 2014·World Journal of Gastroenterology : WJG·Hafez FakheriReza Malekzadeh
Apr 24, 2018·Middle East Journal of Digestive Diseases·Hafez FakheriZohreh Bari
Jun 6, 2017·Critical Reviews in Microbiology·Nasrin MirzaeiHajieh Ghasemian Safaei
May 2, 2020·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Farzad Khademi, Amirhossein Sahebkar
Jun 4, 2017·Digestive Diseases and Sciences·Marjan MohammadiDavid Y Graham
Dec 2, 2020·Helicobacter·Jo-Lewis Banga NdzouboukouXionglin Fan
Jul 28, 2019·Journal of Microbiological Methods·Morteza MilaniYaeghob Sharifi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.